» Articles » PMID: 38049833

How Do Trial Teams Plan for Retention During the Design Stage of the Trial? A Scoping Review

Overview
Journal Trials
Publisher Biomed Central
Date 2023 Dec 4
PMID 38049833
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Retention to trials is important to ensure the results of the trial are valid and reliable. The SPIRIT guidelines (18b) require "plans to promote participant retention and complete follow-up, including list of any outcome data to be collected for participants who discontinue or deviate from intervention protocols" be included in trial protocols. It is unknown how often protocols report this retention information. The purpose of our scoping review is to establish if, and how, trial teams report plans for retention during the design stage of the trial.

Materials And Methods: A scoping review with searches in key databases (PubMed, Scopus, EMBASE, CINAHL (EBSCO), and Web of Science from 2014 to 2019 inclusive) to identify randomised controlled trial protocols. We produced descriptive statistics on the characteristics of the trial protocols and also on those adhering to SPIRIT item 18b. A narrative synthesis of the retention strategies was also conducted.

Results: Eight-hundred and twenty-four protocols met our inclusion criteria. RCTs (n = 722) and pilot and feasibility trial protocols (n = 102) reported using the SPIRIT guidelines during protocol development 35% and 34.3% of the time respectively. Of these protocols, only 9.5% and 11.4% respectively reported all aspects of SPIRIT item 18b "plans to promote participant retention and to complete follow-up, including list of any outcome data for participants who discontinue or deviate from intervention protocols". Of the RCT protocols, 36.8% included proactive "plans to promote participant retention" regardless of whether they reported using SPIRIT guidelines or not. Most protocols planned "combined strategies" (48.1%). Of these, the joint most commonly reported were "reminders and data collection location and method" and "reminders and monetary incentives". The most popular individual retention strategy was "reminders" (14.7%) followed by "monetary incentives- conditional" (10.2%). Of the pilot and feasibility protocols, 40.2% included proactive "plans to promote participant retention" with the use of "combined strategies" being most frequent (46.3%). The use of "monetary incentives - conditional" (22%) was the most popular individual reported retention strategy.

Conclusion: There is a lack of reporting of plans to promote participant retention in trial protocols. Proactive planning of retention strategies during the trial design stage is preferable to the reactive implementation of retention strategies. Prospective retention planning and clear communication in protocols may inform more suitable choice, costing and implementation of retention strategies and improve transparency in trial conduct.

Citing Articles

Retention in the trial in Soweto, South Africa: a qualitative analysis using self-determination theory.

Draper C, Tshetu N, Nkosi N, Lye S, Norris S BMJ Glob Health. 2025; 10(2).

PMID: 39929537 PMC: 11815439. DOI: 10.1136/bmjgh-2024-017729.


Exploratory interviews with Australian clinical research staff on how they communicate with participants.

Wells G, Bowden J, Colyer D, Kay E, Lukeman S, Newett L BMC Med Res Methodol. 2024; 24(1):319.

PMID: 39725896 PMC: 11670412. DOI: 10.1186/s12874-024-02417-w.


Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.

Murphy E, Gillies K, Shiely F Trials. 2024; 25(1):372.

PMID: 38858790 PMC: 11163762. DOI: 10.1186/s13063-024-08194-7.

References
1.
Michael Clark J, Sanders S, Carter M, Honeyman D, Cleo G, Auld Y . Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. J Med Libr Assoc. 2020; 108(2):195-207. PMC: 7069833. DOI: 10.5195/jmla.2020.834. View

2.
Smyth R, Kirkham J, Jacoby A, Altman D, Gamble C, Williamson P . Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ. 2011; 342:c7153. PMC: 3016816. DOI: 10.1136/bmj.c7153. View

3.
Novaes I, Clementino L, Flores-Mir C, Marques L, Martins-Junior P . How to use the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) in orthodontic research. Dental Press J Orthod. 2022; 27(3):e2220290. PMC: 9255961. DOI: 10.1590/2177-6709.27.3.e2220290.oar. View

4.
Dawson S, Banister K, Biggs K, Cotton S, Devane D, Gardner H . Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups-practical guidance to support better practice. Trials. 2022; 23(1):672. PMC: 9383663. DOI: 10.1186/s13063-022-06553-w. View

5.
Walsh M, Srinathan S, McAuley D, Mrkobrada M, Levine O, Ribic C . The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. J Clin Epidemiol. 2014; 67(6):622-8. DOI: 10.1016/j.jclinepi.2013.10.019. View